| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―May―27 |
Cytokine profile and case series of tract-specific myelitis following SARS-CoV-2 infection |
Aleksandra Kozlova, Taras Simaniv, Daria Eliseeva, Evgenii Nuzhnyi, Inessa Zakroyshchikova, Rodion Konovalov, et al. (+2) Ekaterina Baydina, Maria Zakharova |
| 2 |
[GO] |
2024―Sep―09 |
New diagnosis of multiple sclerosis in the setting of recent Sinopharm COVID-19 vaccine (BBIBP-CorV) exposure: A series of clinical cases and updated review of the literature |
Sepideh Paybast, Melika Jameie, Mojtaba Shahbazi, Mohammad Amin Habibi, Seyed Ehsan Mohammadianinejad, Mohammad Hossein Harirchian |
| 3 |
[GO] |
2023―Dec―26 |
Social support and anxiety correlation with resilience in patients with multiple sclerosis during COVID-19 pandemic |
Vahid Shaygannejad, Omid Mirmosayyeb, Aysa Shaygannejad, Saeed Vaheb, Sara Bagherieh, Mozhdeh Askari, Mahsa Ghajarzadeh |
| 4 |
[GO] |
2023―Dec―26 |
Neuro-mucormycosis: Lessons from COVID-19-associated cases |
Nahad Sedaghat, Masoud Etemadifar, Pouria Ghasemi, Mohammad Naghizadeh, Yousef Mokari, Mehri Salari, Bahar Golastani |
| 5 |
[GO] |
2023―Oct―10 |
Abnormalities of brain imaging in COVID-19 patients with neurological symptoms |
Soroor Advani, Seyyed Mohammad Mahdi Hosseini, Rama Bozorgmehr, Arash Khameneh-Bagheri, Sevda Mohammadzadeh, Taha Hasanzadeh, et al. (+4) Laya Jalilian, Mohammad Vahidi, Amir Hasan Nofeli, Zahra Hooshyari |
| 6 |
[GO] |
2023―Oct―10 |
Watershed infarction in COVID-19: The necessity of neuroimaging in patients with subtle neurological symptoms |
Mohammad Amin Najafi, Alireza Zandifar, Mohsen Kheradmand, Luis Octavio Tierradentro-Garcia, Fariborz Khorvash, Arastoo Vossough, Mohammad Saadatnia |
| 7 |
[GO] |
2023―Aug―08 |
Fear of re-infection, relapse, and anxiety during COVID-19 pandemic in patients with multiple sclerosis: A multi-center study |
Abdorreza Naser Moghadasi, Saeed Vaheb, Sara Hamtaei-Ghashti, Aysa Shaygannejad, Mozhdeh Askari, Vahid Shaygannejad, et al. (+2) Mohmmad Ali Sahraian, Mahsa Ghajarzadeh |
| 8 |
[GO] |
2023―May―03 |
The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis |
Nasim Rezaeimanesh, Naghmeh Abbasi, Mohammad Ali Sahraian, Amirreza Azimi, Soodeh Razeghi-Jahromi, Abdorreza Naser Moghadasi |
| 9 |
[GO] |
2023―Jan―17 |
Limited access to health care in patients with atypical parkinsonism during COVID-19 era may lead to higher mortality |
Mehri Salari, Sepand Tehrani-Fateh, Zahra Aminzade, Masoud Etemadifar |
| 10 |
[GO] |
2023―Jan―17 |
Initial clinical presentation of multiple sclerosis with concurrent COVID-19 infection: Case report and literature review |
Zahra Ebadi, Abdorreza Naser Moghadasi |
| 11 |
[GO] |
2023―Jan―17 |
Assessment of COVID-19 vaccine attitude in people with multiple sclerosis, its correlation with demographic factors, and fear of coronavirus: A cross-sectional survey |
Mohammad Reza Fattahi, Arad Iranmehr, Roghayyeh Saeedi, Mohammad Ali Sahraian, Rozita Doosti, Abdorreza Naser Moghadasi |
| 12 |
[GO] |
2023―Jan―17 |
Transient global amnesia after COVID-19: A systematic scoping review of case reports |
Mohsen Farjoud-Kouhanjani, Mohammad Shafie’ei, Mohammad Hossein Taghrir, Zahra Akbari, Seyed Mohammad Amir Hashemi, Zahra Eghlidos, et al. (+2) Afshin Borhani-Haghighi, Abbas Rahimi-Jaberi |
| 13 |
[GO] |
2022―Nov―14 |
The perspective of Iranian patients with multiple sclerosis on the third dose of COVID-19 vaccine |
Fereshteh Ghadiri, Mohammad Ali Sahraian, Amirreza Azimi, Abdorreza Naser Moghadasi |
| 14 |
[GO] |
2022―Jan―12 |
The first presentation of COVID-19 two hours after vaccination in a patient with multiple sclerosis: Can COVID vaccine provoke cytokine storm in a patient with asymptomatic COVID-19? |
Fereshteh Ghadiri, Mohammad Ali Sahraian, Abdorreza Naser Moghadasi |
| 15 |
[GO] |
2022―Jan―12 |
Implementing coronavirus disease 2019 scale-up registry protocol in national multiple sclerosis registry system of Iran |
Sharareh Eskandarieh, Mohammad Ali Sahraian, Abdorreza Naser Moghadasi |
| 16 |
[GO] |
2021―Nov―08 |
Prevalence of coronavirus disease 2019 in patients with neuromyelitis optica in Isfahan, Iran, and a review on recent reports and literature |
Masoud Etemadifar, Mehri Salari, Zahra Aminzade, Sara Ebrahimi, Sepand Tehrani-Fateh |
| 17 |
[GO] |
2021―Nov―08 |
Myasthenia gravis and coronavirus disease 2019: A report from Iran |
Masoud Etemadifar, Mahsa Akafzadeh-Savari, Mehri Salari, Amirhossein Akhavan Sigari, Sara Ebrahimi-Pelarti, Nahad Sedaghat, Koorosh Etemad |
| 18 |
[GO] |
2021―Jun―15 |
Magnetic resonance imaging of sudden-onset anosmia in COVID-19 infection |
Morteza Sanei-Taheri, Zahra Mahboubi-Fooladi, Reza Soleimani |
| 19 |
[GO] |
2021―Jun―15 |
Severe acute respiratory syndrome coronavirus 2 and seizure: An insight into the pathophysiologic mechanisms |
Shima Zareh-Shahamati, Mahyar Noorbakhsh, Hadi Digaleh, Behnam Safarpour-Lima, Behnam Safarpour-Lima |
| 20 |
[GO] |
2021―Feb―24 |
Parkinsonism management issues in a patient with exhausted subthalamic deep brain stimulation battery, stricken by severe acute respiratory syndrome coronavirus 2 |
Seyed Amir Hassan Habibi, Luigi Romito, Oldooz Aloosh, Mohammad Rohani, Fatemeh Moghadas, Mansour Parvaresh, et al. (+4) Gholamali Shahidi, Mehdi Moghaddasi, Ehsan Ziayi, Maziar Emamikhah |
| 21 |
[GO] |
2021―Feb―17 |
We need well-designed multicenter studies to investigate neurologic manifestations of coronavirus disease 2019 |
Mahmoud Reza Ashrafi, Mahmoud Mohammadi, Gholamreza Zamani, Nahid Khosroshahi, Reza Shervin Badv, Alireza Tavasoli, et al. (+3) Morteza Heidari, Bahram Yarali, Reza Azizimalamiri |
| 22 |
[GO] |
2021―Feb―17 |
Guillain-Barre syndrome in patients with coronavirus disease-2019: Report of six cases and review of literature |
Ali Asghar Okhovat, Behnaz Ansari, Helia Hemasian, Bahram Haghi-Ashtiani, Soroor Advani, Bentolhoda Ziaadini, et al. (+4) Siamak Abdi, Hajir Sikaroudi, Shahriar Nafissi, Farzad Fatehi |
